南洋理工大学徐臣杰教授7月17日上午学术报告

发布时间:2017-07-11访问量:1149设置

报告人:Assis. Prof.Chenjie Xu, Nanyang Technological University 

报告题目:Micro/nanotechnology for treatment and diagnosis of abnormal scar

报告时间:1000 AM, July 17th (Monday)

报告地点:909-B

  

Abstract

Abnormal scars result from over-exuberant wound healing and cause significant pain, impair mobility, and psychological anguish. Current standard of care is inadequate and lack of acceptable therapeutics and diagnostics. Molecular diagnostics are favourable in identifying high-risk wounds before maturity. To date, abnormal scars are diagnosed through symptomatic and visual appearance. Molecular diagnostics provide clinicians with better information to make good clinical decision and early interventions, and to monitor the treatment progress. On the other hand, therapeutics are dissatisfactory due to: lack of efficacy, patient experiencing pain and involvement of healthcare personnel. Developing self-applied therapeutics minimizes healthcare personnel involvement and reduces overall healthcare burden. Dr. Chenjie Xu’s laboratory is dedicated to address these challenges by using the latest development in micro/nanotechnologies. In this talk, he will provide an update about their effort in technology development.

  

Biography


Dr. XU Chenjie received his B.S. from Nanjing University (2002, China), and M.Phil. from Hong Kong University of Science and Technology (2004, Hong Kong). After one-year internship at Stanford University (2005), he continued his Ph.D. study at Brown University (RI, 2005-2009). He was awarded Vince Wernig Fellowship (2007-2008), Joukowsky Outstanding Dissertation Prize (2009), and Potter Prize for Outstanding Doctoral Thesis (2009). From 2009-2012, Dr. XU was a research associate in the Harvard-MIT Health Sciences and Technology (HST) Program and Harvard medical school. He joined Nanyang Technological University as an Assistant Professor in August 2012. Dr. XU has published over 90 papers in total and edited five book chapters. He has contributed significantly to the field of nanomedicine or medical applications of nanomaterials such as molecular imaging and drug delivery. His publications have a total ISI citation of over 6000 and an H-index of 29. He also holds several patents in nanomaterials for molecular imaging and drug delivery.

  

Contact: Prof. Zhuang Liu


返回原图
/